Phase II Trial of Rituximab In Myasthenia Gravis

Diseases and Conditions Researched

Myasthenia Gravis


Participation Guidelines

Age: 21 Years - 90 Years
Gender: Both

Click here for detailed participation information for this trial.

Sponsor: Yale University
Dates: April 7, 2014
Last Updated: May 9, 2014
Study HIC#: 1401013253
Clinicaltrials.gov ID: NCT02110706